1. J.N. Galgiani. Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies. Rev Inf Dis. 12: Supple 3: S272 - S275, 1990.
2. M.A. Pfaller, B. DuPont, G.S. Kobayashi, J. Muller, M.G. Rinaldi, A.Espinal-Ingroff, S. Shadomt, P.F. Troke, T.J. Walsh, and D.W. Warnock. Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob Agents Chemother. 36: 1805–1809, 1992.
3. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard. NCCLS Document M27-P. National Committee for Clinic] laboratory Standards, Villanova, Pa. 1992.
4. R. Horn, B. Wong, T.E. Keihn, and D. Armstrong. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Inf Dis. 7: 646–655, 1985.
5. V.J. Fraser, M. Jones, J. Dunkel, S. Storfer, G. Medoff, and W.C.Dunagan. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 15: 414–421, 1992.